Literature DB >> 2143820

Antidepressants in the management of chronic pain syndromes.

I G Egbunike1, B J Chaffee.   

Abstract

Conditions in which antidepressants have been used include diabetic neuropathy, postherpetic neuralgia, headaches, arthritis, chronic back pain, cancer, thalamic pain, facial pain, and phantom limb pain. Although much of the available information is derived from inadequately controlled trials, it seems that antidepressants provide analgesia in many of these disorders. The analgesic effects tend to be independent of antidepressant effects, and doses of heterocyclic antidepressants used for analgesia seem to be lower than those considered effective in the treatment of depression. Doses should be started low and gradually increased until the patient reaches the highest tolerable dose. Onset of analgesia is variable, ranging from 1 day to 10 weeks. Common side effects include dry mouth, drowsiness, urinary retention, orthostatic hypotension, and constipation. Optimum dosages and schedules have not been established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143820

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  19 in total

Review 1.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Paroxetine for somatic pain associated with physical illness: a review.

Authors:  Prakash S Masand; Meera Narasimhan; Ashwin A Patkar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 3.  Pharmacoeconomics of chronic nonmalignant pain.

Authors:  M J Zagari; P D Mazonson; W C Longton
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

4.  Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats.

Authors:  V Hajhashemi; H Sadeghi; M Minaiyan; A Movahedian; A Talebi
Journal:  Inflamm Res       Date:  2010-06-24       Impact factor: 4.575

5.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

6.  Tricyclic antidepressant amitriptyline inhibits autophagic flux and prevents tube formation in vascular endothelial cells.

Authors:  Yinglu Guan; Xiang Li; Michihisa Umetani; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-11-15       Impact factor: 4.080

Review 7.  Antidepressants for functional gastrointestinal syndromes.

Authors:  R E Clouse
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

8.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

9.  Imipramine decreases oesophageal pain perception in human male volunteers.

Authors:  P L Peghini; P O Katz; D O Castell
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

10.  A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.

Authors:  L Bendtsen; R Jensen; J Olesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.